Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1

Physiological Genomics

Volumn 2001, Issue 6, 2001, Pages 39-43

  Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Blood pressure; Endothelin; Renal hemodynamics; Water electrolyte balance

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; PROTEIN PRECURSOR; PYRROLIDINE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENE DELETION; GENETICS; HEMATOCRIT; KIDNEY; KIDNEY PLASMA FLOW; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTHELINS; GENE DELETION; HEMATOCRIT; KIDNEY; PROTEIN PRECURSORS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RENAL PLASMA FLOW; URINE;

EID: 0346451201     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.2001.6.1.39     Document Type: Article

References (18)

1. Gariepy CE, Cass DT, and Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93: 867-872, 1996.
2. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, and Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000.
3. Gariepy CE, Williams SC, Richardson JA, Hammer RE, and Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J Clin Invest 102: 1092-1101, 1998.
4. Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, and Winaver J. Differential regulation of renal regional blood flow by endothelin-1. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1166-F1172, 1996.
5. B receptors. Hypertension 35: 732-739, 2000.
6. B in human kidney. Kidney Int 44: 36-42, 1993.
7. 2 accumulation in rat IMCD. Am J Physiol Renal Fluid Electrolyte Physiol 265: F670-F676, 1993.
8. Nambi P, Pullen M, Wu HL, Aiyar N, Ohlstein EH, and Edwards RM. Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131: 1081-1086, 1992.
9. B receptor-mediated NO release. Am J Physiol Renal Physiol 279: F326-F333, 2000.
10. Pollock DM. Endothelin Receptor Subtypes and Tissue Distribution. In: Endothelin Molecular Biology, Physiology, and Pathology, edited by Highsmith RF. Totowa, NJ: Humana, 1998.
11. Pollock DM, Divish BJ, Novosad EI, Burres NS, and Opgenorth TJ. In vivo characterization of a phosphoramidon-sensitive endothelin converting enzyme in the rat. Eur J Pharmacol 231: 459-464, 1993.
12. Pollock DM and Opgenorth TJ. Comparison of the hemodynamic effects of endothelin-1 and big endothelin-1 in the rat. Biochem Biophys Res Commun 179: 1122-1126, 1991.
13. Pollock DM and Opgenorth TJ. Evidence for metalloprotease involvement in the in vivo effects of big endothelin-1. Am J Physiol Regulatory Integrative Comp Physiol 261: R257-R263, 1991.
14. A receptor activation. Am J Physiol Regulatory Integrative Comp Physiol 264: R222-R226, 1993.
15. A receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Br J Pharmacol 111: 729-732, 1994.
16. Pollock DM, Portik-Dobos V, Procter C, Gariepy CE, and Yanagisawa M. Arterial pressure response to endothelin-1 and sarafotoxin 6c in rescued endothelin-B-deficient rats. J Cardiovasc Pharmacol 36, Suppl 1: S82-S85, 2000.
17. Rubanyi GM and Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415, 1994.
18. von Geldern TW, Tasker AS, Sorensen BK, Winn M, Szczepankiewicz BG, Dixon DB, Chiou WJ, Wang L, Wessale JL, Adler A, Marsh KC, Nguyen B, and Opgenorth TJ. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity. J Med Chem 42: 3668-3678, 1999.